Interactions of Coexisting Neurotransmitters and Effects of Chronic Drug Treatment
The phenomenon of coexistence of classical neurotransmitters and neuroactive peptides has been demonstrated in a number of cases in the central and peripheral nervous system (cf. Hökfelt et al., 1980; Cuello, 1982; Lundberg and Hökfelt, 1983). In the descending bulbospinal pathway originating from the raphe nuclei, coexistence of at least three putative neurotransmitters; the undecapeptide substance P (SP), the tripeptide thyrotropinreleasing hormone (TRH) and serotonin (5-hydroxytryptamine, 5-HT) has been shown using immunohistochemical methods (Chan-Palay et al., 1978; Hökfelt et al., 1978; Johansson et al., 1981). Treatment with the serotonergic “neurotoxins” 5,6- or 5,7-dihydroxytryptamine results in an almost complete loss of 5-HT, TRH and SP immunoreactive fibers in the ventral spinal cord (Björklund et al., 1979; Johansson et al., 1981; Gilbert et al., 1982; Marsden et al., 1982) although findings suggesting a limited scope of coexistence only, were also reported (Towle et al., 1986).
KeywordsSpinal Cord Lumbar Spinal Cord Tachykinin Receptor Classical Neurotransmitter Ventral Spinal Cord
Unable to display preview. Download preview PDF.
- Björklund, A.J., Emson, P.C., Gilberg, R.F.T. and Shagerberg, G. (1979) Further evidence for the possible coexistence of 5-hydroxytryptamine and substance P in medullary raphe neurons of the rat brain. Br. J. Pharmacol., 66, 112P - 113 P.Google Scholar
- Brodin, E., Peterson, L.-L., Ogren, S.-O. and Bartfai, T. (1984) Chronic treatment with serotonin uptake inhibitor zimelidine elevates substance P levels in rat spinal cord. Acta Physiol. Scand., 122, 209–211.Google Scholar
- Cuello, A.C. (1982) Cotransmission. MacMillan Press, London.Google Scholar
- Göthert, M. (1980) Serotonin-receptor-mediated modulation of Ca2+ dependent 5-hydroxytryptamine release from neurons of the rat brain cortex. Naunyn-Schmiedeberg’s Arch. Pharmacol., 314, 223–230.Google Scholar
- Hökfelt, T., Ljungdahl, A., Steinbuch, H., Verhofstad, A., Nilsson, G., Brodin, E., Pernow, B. and Goldstein, M. (1978) Immunohistochemical evidence of substance P-like immunoreactivity in some 5-hydroxytryptamine-containing neurons in the rat central nervous system. Neuroscience, 3, 517–538.CrossRefGoogle Scholar
- Iverfeldt, K., Peterson, L.-L., Brodin, E., Ogren, S.-O. and Bartfai, T. (1986) Serotonin type-2 receptor mediated regulation of substance P release in the ventral spinal cord and the effects of chronic antidepressant treatment. Naunyn-Schmiedeberg’s Arch. Pharmacol., 333, 1–6.Google Scholar
- Johansson, O., Hökfelt, T., Pernow, B., Jeffcoate, S.L., White, N., Steinbusch, H.W.M., Verhofstad, A.A.J., Emson, P.C. and Spindel, E. (1981) Immunohistochemical support for three putative transmitters in one neuron: coexistence of 5-hydroxytryptamine, substance P and thyrotropin releasing hormone-like immunoreactivity in medullary neurons projecting to the spinal cord. Neuroscience, 6, 1857–1881.CrossRefGoogle Scholar
- McKelvy, J.F. (1982) Biosynthesis of thyrotropin releasing hormone. Front. Horm. Res., 10, 73–84.Google Scholar
- Richter, K., Kawashima, E., Egger, R. and Kreil, G. (1984) Biosynthesis of thyrotropin releasing hormone in the skin of Xenopus laevis: partial sequence of the precursor deduced from cloned cDNA. EMBO J., 3, 617–621.Google Scholar
- Solti, M. and Bartfai, T. (1987) Tachykinin regulation of serotonin release: enhancement of [3H]serotonin release from rat cerebral cortex by neuromedin K and substance P acting at distinct receptor sites. Brain Res., in press.Google Scholar